Amundi’s Increased Stake in MicroStrategy Could Not Be Verified Before Shares Fell to $128.93
Key Facts
The reported increase in Amundi’s holdings in MicroStrategy, and its size, could not be verified because no reliable disclosure confirming the claim attributed to the company was available. It is therefore not possible to confirm that shares were added or determine when such a purchase was made. A disclosure of share ownership alone also does not establish that the investment was driven by the company’s bitcoin-buying strategy. Meanwhile, MSTR closed at $128.93 on November 6, 2026, according to EL7 data. Amundi shares closed at €93.95 in the same session, placing the two stocks’ performance in the context of the trading day without confirming a change in Amundi’s ownership.
MSTR’s November 6 close followed a close of $129.3 on November 5, while it closed at $142.54 on November 4. These prices show a decline in the closing price between November 4 and 6, without identifying its causes on their own. In a separate filing with the U.S. Securities and Exchange Commission, Strategy said it bought 811 bitcoin between October 26 and November 1, 2026. The purchases were valued at $65.5 million, at an average price of $80,846 per bitcoin. The filing concerns Strategy’s own activity and does not establish that Amundi increased its stake in the company.
Strategy said in the filing that its holdings stood at 849,327 bitcoin on November 1, at a total cost of $64.08 billion and an average cost of $75,451 per coin. These are aggregate figures for the company’s portfolio on that date, not evidence of the size of any outside investor’s holdings. The company said net proceeds from sales of MSTR shares funded its bitcoin purchases during the same period, while $98.5 million was allocated in cash in U.S. dollars. Strategy thus linked stock issuance to funding digital currency purchases in its disclosed operations. This does not explain an investment decision attributed to Amundi.
Between October 26 and November 1, Strategy sold 1,178,552 MSTR shares under its at-the-market sales program, generating net proceeds of $164 million. The filing also said its dollar reserve stood at $4.79 billion on November 1, alongside $132.7 million in cash in U.S. dollars. These figures provide a picture of the funding sources and liquidity the company disclosed on that date. They do not establish that Amundi bought additional shares or support an inference about a broader trend among financial institutions. The reported change in Amundi’s stake remains unconfirmed in the available information.